Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of DR-01 for alopecia areata and vitiligo is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DR-01

Snippet

Sponsor: Dren Bio | Conditions: Alopecia Areata, Vitiligo | Phase 1 | Status: RECRUITING